Officer of Vor Biopharma Inc. (NASDAQ:VOR), recently sold shares of the company's common stock, according to a filing with the Securities and Exchange Commission. The transaction, which occurred on ...
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are presently covering the company, Marketbeat Ratings ...
Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results